SCHEMBL11297461

SCHEMBL11297461

O=C1CC(N(c2ccc(C(=O)NO)cc2)c2ccccc2Cl)CN1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 14/20 0.37
▸ HDAC6 Q9UBN7 11/20 0.37
▸ HDAC1 Q13547 9/20 0.37
▸ HDAC2 Q92769 3/20 0.34
▸ ALOX15 P16050 2/20 0.34
▸ HDAC3 O15379 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ IDO1 P14902 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ HDAC7 Q8WUI4 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ NCOR2 Q9Y618 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ ADAM17 P78536 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297190 0.86 HDAC6 (0.44) HDAC8HDAC6HDAC1HDAC2ALOX15
SCHEMBL11303497 0.85 HDAC8 (0.46) HDAC8HDAC6HDAC1HDAC2ALOX15
SCHEMBL11303321 0.81 HDAC8 (0.44) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL11300774 0.80 HDAC6 (0.41) HDAC8HDAC6HDAC1ALOX15HDAC3
SCHEMBL11299163 0.78 HDAC6 (0.40) HDAC8HDAC6HDAC1HDAC2ALOX15
SCHEMBL11296626 0.74 HDAC8 (0.49) HDAC8HDAC1CA1KDM4E
SCHEMBL11299059 0.74 HDAC6 (0.48) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL11299511 0.72 HDAC8 (0.41) HDAC8HDAC6HDAC1HDAC2ALOX15
SCHEMBL11372589 0.72 HDAC1 (0.48) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL11301919 0.72 HDAC1 (0.48) HDAC8HDAC6HDAC1HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback